ArticlePloS one2021

Plasminogen Activator Inhibitor-1 in poorly controlled vs well controlled Type-2 Diabetes Mellitus patients: A case-control study in a district hospital in Ghana.

Charles Nkansah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.